Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans Read More Nov 21, 2024
Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to it’s Board of Directors Read More Oct 16, 2024
Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Read More Sep 23, 2024
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors Read More Sep 19, 2024
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering Read More Jul 23, 2024
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors Read More Jul 9, 2024
